Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hakan Nazlı"'
Publikováno v:
Pharmaceutics, Vol 15, Iss 5, p 1509 (2023)
Aprepitant is the first member of a relatively new antiemetic drug class called NK1 receptor antagonists. It is commonly prescribed to prevent chemotherapy-induced nausea and vomiting. Although it is included in many treatment guidelines, its poor so
Externí odkaz:
https://doaj.org/article/896e8cefeffc4d17ad10e2169d10e433
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1089 (2021)
Aprepitant (APR) belongs to Class II of the Biopharmaceutical Classification System (BCS) because of its low aqueous solubility. The objective of the current work is to develop self-nanoemulsifying drug delivery systems (SNEDDS) of APR to enhance its
Externí odkaz:
https://doaj.org/article/5372e58bda8f4188b6ff6eb7d2f6e099
Autor:
Hakan Nazlı, Gülşah Gedik
Publikováno v:
Pharmaceutical Development and Technology. 26:750-764
The aim of this study is, preparing various dendrimeric formulations of oxaliplatin and investigating their properties. First of all, the solubility enhancement capabilities of polyamidoamine (PAMA...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8970bacb05f8b90f062d00ddebd43139
https://doi.org/10.1080/10837450.2021.1944205
https://doi.org/10.1080/10837450.2021.1944205
Publikováno v:
Volume: 50, Issue: 3 216-223
İstanbul Journal of Pharmacy
İstanbul Journal of Pharmacy
WOS:000605357000010 Background and Aims: Fomes fomentarius (L.) Fr. (jar fungus) has been used extensively in the past by surgeons, barbers, dentists, and is therefore called surgeon's fungus. The hemostatic properties of F. fomentarius extracts are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273c45719303558354d0151f5bc29754
https://dergipark.org.tr/tr/pub/iujp/issue/42667/850140
https://dergipark.org.tr/tr/pub/iujp/issue/42667/850140
Publikováno v:
Pharmaceuticals
Pharmaceuticals, Vol 14, Iss 1089, p 1089 (2021)
Volume 14
Issue 11
Pharmaceuticals, Vol 14, Iss 1089, p 1089 (2021)
Volume 14
Issue 11
Aprepitant (APR) belongs to Class II of the Biopharmaceutical Classification System (BCS) because of its low aqueous solubility. The objective of the current work is to develop self-nanoemulsifying drug delivery systems (SNEDDS) of APR to enhance its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187ce315ee699fa93dab7987eec0cc6e
https://doi.org/10.3390/ph14111089
https://doi.org/10.3390/ph14111089
Publikováno v:
MARMARA PHARMACEUTCAL JOURNAL. 20:44
Biyofarmasotikler, biyoteknoloji kullanilarak biyolojik kaynaklardan elde edilen buyuk ve kompleks ilaclardir. Biyofarmasotiklerin uretiminde, canli organizmalarin kullanilmasi ve uretim yontemlerinin kompleks olmasi nedeniyle ayni ureticinin yaptigi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0373c1a10652b3518da7c54cd395998c
https://doi.org/10.12991/mpj.20164450877
https://doi.org/10.12991/mpj.20164450877
Autor:
Nazlı, Hakan1 (AUTHOR) hakannazli@trakya.edu.tr, Mesut, Burcu2 (AUTHOR) bmesut@istanbul.edu.tr, Akbal-Dağıstan, Özlem2 (AUTHOR) ozlemakbal@istanbul.edu.tr, Özsoy, Yıldız2 (AUTHOR) yozsoy@istanbul.edu.tr
Publikováno v:
Pharmaceutics. May2023, Vol. 15 Issue 5, p1509. 22p.
Autor:
Nazlı, Hakan1 (AUTHOR), Gedik, Gülşah1 (AUTHOR)
Publikováno v:
Pharmaceutical Development & Technology. Sep2021, Vol. 26 Issue 7, p750-764. 15p.
Autor:
KORUCU, Fatma Ceyda1 hakannazli@trakya.edu.tr, NAZLI, Hakan1 gulsahgedik@trakya.edu.tr, GEDİK, Gülşah2 fceydakorucu@trakya.edu.tr, ÇİÇİN, İrfan3 irfancicin@hotmail.com
Publikováno v:
Marmara Pharmaceutical Journal. 2016, Vol. 20 Issue 1, p44-51. 8p.
Autor:
Nazlı, Hakan1 (AUTHOR) hakannazli@trakya.edu.tr, Mesut, Burcu2 (AUTHOR) bmesut@istanbul.edu.tr, Özsoy, Yıldız2 (AUTHOR) yozsoy@istanbul.edu.tr
Publikováno v:
Pharmaceuticals (14248247). Nov2021, Vol. 14 Issue 11, p1089. 1p.